Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell Products, Inc. is a life science company specializing in the development and distribution of anti-aging supplements and cosmetic products designed to support stem cell function and cellular longevity. Founded in 2005 by Dr. Vincent Giampapa, a prominent figure in regenerative medicine and anti-aging, the company offers a range of science-based products, including its flagship Stem Cell 100 and Stem Cell 100 Plus supplements. These products utilize proprietary blends of natural compounds aimed at enhancing the body's natural repair mechanisms and promoting healthy aging. The company operates primarily through online retail channels and focuses on translating advanced cellular research into accessible consumer health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell Products.